Claim Your New User Special: Get your second month free ▶ Second Month Free

Serving leading biopharmaceutical companies globally:

Colorcon
Boehringer Ingelheim
Johnson and Johnson
Moodys
Baxter
AstraZeneca

Last Updated: May 26, 2022

ADRENALIN Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard

When do Adrenalin patents expire, and what generic alternatives are available?

Adrenalin is a drug marketed by Par Sterile Products and is included in two NDAs. There are three patents protecting this drug and two Paragraph IV challenges.

This drug has seven patent family members in seven countries.

The generic ingredient in ADRENALIN is epinephrine. There are twenty-one drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the epinephrine profile page.

Drug patent expirations by year for ADRENALIN
Drug Prices for ADRENALIN

See drug prices for ADRENALIN

Drug Sales Revenue Trends for ADRENALIN

See drug sales revenues for ADRENALIN

Paragraph IV (Patent) Challenges for ADRENALIN
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
ADRENALIN Injection epinephrine 30 mg/30 mL 204640 1 2018-08-20
ADRENALIN Injection epinephrine 1 mg/mL ampules 204200 1 2016-03-09

US Patents and Regulatory Information for ADRENALIN

ADRENALIN is protected by three US patents.

Patents protecting ADRENALIN

Epinephrine formulations
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing

Epinephrine formulations
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing

Epinephrine formulations
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: EMERGENCY TREATMENT OF ALLERGIC REACTIONS (TYPE I), INCLUDING ANAPHYLAXIS

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Par Sterile Products ADRENALIN epinephrine SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS 204200-001 Dec 7, 2012 RX Yes Yes See Plans and Pricing See Plans and Pricing See Plans and Pricing
Par Sterile Products ADRENALIN epinephrine SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS 204640-001 Dec 18, 2013 AP RX Yes Yes See Plans and Pricing See Plans and Pricing Y See Plans and Pricing
Par Sterile Products ADRENALIN epinephrine SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS 204200-001 Dec 7, 2012 RX Yes Yes See Plans and Pricing See Plans and Pricing Y See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for ADRENALIN

See the table below for patents covering ADRENALIN around the world.

Country Patent Number Title Estimated Expiration
European Patent Office 3268045 FORMULATIONS D'ÉPINÉPHRINE (EPINEPHRINE FORMULATIONS) See Plans and Pricing
Australia 2016233682 Epinephrine formulations See Plans and Pricing
Japan 2018507915 エピネフリン製剤 See Plans and Pricing
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
McKesson
Merck
AstraZeneca
Medtronic
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.